Best in Biotech 16 Jan 2025 Ten first-in-class drugs on track for FDA approval in 2025 As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025. January 16, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Dec 2024 10 biotech companies to watch in 2025 As 2025 is expected to be an exciting year for the biopharma industry, discover ten biotech companies to keep an eye on in 2025. December 16, 2024 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Nov 2024 Six antisense oligonucleotide companies shaping the future of genetic medicine Learn more about six antisense oligonucleotide companies shaping the future of genetic medicine, just as the market is expected to grow. November 28, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Nov 2024 Seven miRNA-focused companies pioneering new therapies in 2024 Delve into the field of miRNA with seven companies with miRNA-focused candidates in the pipeline in 2024, from oncology to neurodegeneration. November 26, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 23 Oct 2024 RNA editing in humans: the race begins with first successful trial Wave Life Sciences achieves RNA editing in the clinic, crossing a major milestone in the space. October 23, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Angelini Pharma 15 Oct 2024 The future of epilepsy treatment: pioneering advances and patient-centric care Epilepsy, one of the most widespread neurological diseases in the world, characterized by recurrent seizures, affects approximately 50 million people globally. In Europe, up to six million people are estimated to be living with the disease. Whilst treatment options have come a long way over the last few decades, clinical practice still shows significant unmet […] October 15, 2024 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 27 Sep 2024 Aptadir Therapeutics launches to develop new class of RNA inhibitors against cancer and genetic disorders Italian startup Aptadir Therapeutics has launched with $1.6 million to bring a new class of drugs to the clinic and a technology to be reckoned with. September 27, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2024 Long non-coding RNAs: what’s behind the growing “dark genome” buzz? Recent deals have zoned in on drugs that target long non-coding RNAs and major moves are currently being made on the R&D front. September 10, 2024 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 9 Aug 2024 The therapeutic potential of circular RNA: Could it soon trump mRNA technology? Find out about circular RNA, an emerging technology that could hold a lot of promise for next-generation vaccines and gene therapies. August 9, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Jun 2024 Eight biotech companies advancing the field of siRNA Explore the growing sector of siRNA and discover eight biotech companies spearheading this innovative field. June 6, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Apr 2024 5 RNA editing companies you should know about Check out five RNA editing companies on a mission to find a safer alternative to traditional gene editing techniques. April 18, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 10 Apr 2024 Silencing genes to cure diseases: an in-depth look at siRNA Delve into the promissing and dynamic sector of siRNA technology, with new drug approvals and advancements in delivery methods. April 10, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email